Table 3 The detailed clinical postoperative course of the propensity-matched patients of the Redo-TAVI and Redo-AVR group
All patients | Propensity-matched patients | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Redo-TAVI (n = 52) | Redo-AVR (n = 167) | p value | Redo-TAVI (n = 40) | Redo-AVR (n = 40) | p value | |||||
Variables | No. | (%) | No. | (%) | No. | (%) | No. | (%) | ||
Ventilation time (h) | 8 ± 6 | 18 ± 24 | 0.07 | 9 ± 7 | 31 ± 41 | 0.04 | ||||
ICU stay (h)† | 25 ± 21 | 65 ± 68 | 0.04 | 23 ± 20 | 74 ± 97 | 0.03 | ||||
Postoperative complications | ||||||||||
Bleeding complications | ||||||||||
Postop. chest tube drainage (ml/24 h)§ | 144 ± 209 | 580 ± 420 | 0.05 | 163 ± 214 | 562 ± 332 | 0.02 | ||||
Surgical reexploration | 2 (4) | 13 (8) | 0.09 | 1 (3) | 7 (17) | 0.05 | ||||
Transfusion rate of allogenic | ||||||||||
Blood products | ||||||||||
PRBC (U)|| | 1 ± 1 | 6 ± 6 | 0.03 | 1 ± 1 | 6 ± 6 | 0.04 | ||||
FFP (U)* | 1 ± 1 | 5 ± 5 | 0.04 | 1 ± 1 | 4 ± 3 | 0.05 | ||||
PC (U)‡ | 0 | 4 ± 2 | 0.01 | 0 | 4 ± 1 | 0.01 | ||||
Low cardiac output | 2 (4) | 4 (2) | 0.23 | 2 (5) | 2 (5) | >0.99 | ||||
Acute kidney injury | ||||||||||
Creatinin increase >300% | 3 (5) | 6 (4) | 0.18 | 1 (3) | 2 (5) | 0.09 | ||||
Permanent PM implantation^ | 1 (2) | 5 (3) | 0.21 | 0 | 3 (8) | 0.31 | ||||
Cerebrovascular | ||||||||||
TIA¶ | 2 (4) | 4 (2) | 0.23 | 1 (3) | 2 (5) | 0.09 | ||||
Major stroke (Rankin score >2) | 0 | 7 (4) | 0.07 | 0 | 5 (13) | 0.04 | ||||
Wound healing disorder | ||||||||||
Conservative treatment | 0 | 11 (7) | 0.04 | 0 | 2 (5) | 0.06 | ||||
Surgical treatment | 0 | 6 (4) | 0.05 | 0 | 1 (3) | 0.07 | ||||
Thirty day mortality | 3 (6) | 14 (8) | 0.14 | 3 (8) | 6 (16) | 0.06 | ||||